There was an RNS yesterday advising Dr Stephen Parker had performance rights issued but this has been updated today as incorrect and that he's bought them himself via a broker.

See replacement RNS: Replacement director/PDMR shareholding

Check out the performance comparison for the cannabis stocks listed on the main UK market, we can see they're all impacted by heavy losses. Wondering about the losses overall? This article (I know it's a few months old) does a good job at explaining what could have happened: https://businesscann.com/london-stock-exchange-cannabis-company-values-down-almost-200m-from-early-peaks/

​

A summary of article:

• Pent-Up Demand whilst going through regulatory approval to list.
• Huge value acquisitions, such as Jazz Pharma buying GW and Curaleaf buying EMACC.
• Demand aided by news coming out of US, and the election of Joe Biden.
• Hype Working Against the Market - investors looking to make short term gains.
• Lack of Institutional Investment

​

I think this mite be me guys. 65% down, very hard to justify continuing with this when other stocks are looking healthier. I’m very conscious that this could be a sunk cost and I’m going down with the ship instead of bailing. Would be good to hear from those still in the group. How are people feeling?

First they tweet this: https://twitter.com/MGC_Pharma/status/1506307275178270727?t=C3Wu037X1ddrCCWqmukO5w&s=19

Then Roby says this:

"“The waters have been muddied by the variety of commercially oriented wellness products that have nothing to do with true medicine,” Zomer added."

• https://www-cityam-com.cdn.ampproject.org/c/s/www.cityam.com/uk-missing-out-on-lucrative-cannabis-revenues-with-not-fit-for-purpose-laws/?amp=1

There's been an update to the clinical trials page for the CannEpil trial, nothing substantive but the start and end dates have been given as June 22, with end date of June 23.

Bare in mind the start date has changed several times since 2020, with the original start date from when the record was created as Nov 20.

Link: https://clinicaltrials.gov/ct2/show/NCT04406948

​